Skip to content
10-Q/A

Quarterly Report

ASSURED PHARMACY, INC.

0001117768-15-000410

← back to feed
Filed
May 19, 2015 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Apr 15, 2015 13.35M sh
Capex Q3 2014 · Sep 30, 2014 $11.74K
Capex Q3 2014 · Sep 30, 2013 $47.65K
Operating Cash Flow Q3 2014 · Sep 30, 2014 −$921K
Operating Cash Flow Q3 2014 · Sep 30, 2013 −$1.23M
Cash And Equivalents Q3 2014 · Sep 30, 2014 $7.93K
Cash And Equivalents Q3 2014 · Dec 31, 2013 $2.86K
Cash And Equivalents Q3 2014 · Sep 30, 2013 $6.61K
Cash And Equivalents Q3 2014 · Dec 31, 2012 $21.3K
Stockholders Equity Q3 2014 · Sep 30, 2014 −$12.62M
Stockholders Equity Q3 2014 · Dec 31, 2013 −$10.47M
Current Liabilities Q3 2014 · Sep 30, 2014 $6.71M
Current Liabilities Q3 2014 · Dec 31, 2013 $5.98M
Total Liabilities Q3 2014 · Sep 30, 2014 $9.56M
Total Liabilities Q3 2014 · Dec 31, 2013 $9M
Current Assets Q3 2014 · Sep 30, 2014 $710.07K
Current Assets Q3 2014 · Dec 31, 2013 $830.28K
Total Assets Q3 2014 · Sep 30, 2014 $913.52K
Total Assets Q3 2014 · Dec 31, 2013 $1.05M
Sga Expense Q3 2014 · Sep 30, 2014 $504.68K
Sga Expense Q3 2014 · Sep 30, 2014 $1.42M
Sga Expense Q3 2014 · Sep 30, 2013 $303.94K
Sga Expense Q3 2014 · Sep 30, 2013 $1.62M
Net Income Q3 2014 · Sep 30, 2014 −$685.28K
Net Income Q3 2014 · Sep 30, 2014 −$1.36M
Net Income Q3 2014 · Sep 30, 2013 −$837.31K
Net Income Q3 2014 · Sep 30, 2013 −$3.82M
Gross Profit Q3 2014 · Sep 30, 2014 $410.22K
Gross Profit Q3 2014 · Sep 30, 2014 $1.16M
Gross Profit Q3 2014 · Sep 30, 2013 $217.67K
Gross Profit Q3 2014 · Sep 30, 2013 $912.82K
Cost Of Revenue Q3 2014 · Sep 30, 2014 $1.91M
Cost Of Revenue Q3 2014 · Sep 30, 2014 $4.96M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $708.89K
Cost Of Revenue Q3 2014 · Sep 30, 2013 $3.09M
Revenue Q3 2014 · Sep 30, 2014 $2.32M
Revenue Q3 2014 · Sep 30, 2014 $6.12M
Revenue Q3 2014 · Sep 30, 2013 $926.55K
Revenue Q3 2014 · Sep 30, 2013 $4M